Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,150 | 9,651 | 11,448 | 12,918 | 14,066 |
| TOTAL | $8,445 | $9,931 | $11,553 | $13,150 | $14,416 |
| Non-Current Assets | |||||
| PPE Net | 8,107 | 8,291 | 8,418 | 8,557 | 8,694 |
| Intangibles | 334 | 336 | 338 | 340 | 342 |
| Other Non-Current Assets | 14 | 19 | 27 | 36 | 43 |
| TOTAL | $8,455 | $8,646 | $8,782 | $8,933 | $9,079 |
| Total Assets | $16,900 | $18,577 | $20,335 | $22,082 | $23,495 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 24 | 95 |
| Accounts payable and accrued liabilities | 391 | 307 | 39 | 471 | 272 |
| Accrued Expenses | 144 | 42 | 52 | 24 | 46 |
| TOTAL | $534 | $349 | $465 | $518 | $413 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,500 | 0 | 0 | 0 | 0 |
| TOTAL | $1,500 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,034 | $349 | $465 | $518 | $413 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,746 | 11,666 | 11,635 | 11,610 | 11,592 |
| Common Shares | 0 | 12 | 12 | 12 | 0 |
| Retained earnings | -131,081 | -127,511 | -125,808 | -124,063 | -122,492 |
| Other shareholders' equity | 0 | 1 | 1 | 1 | 0 |
| TOTAL | $14,866 | $18,228 | $19,870 | $21,564 | $23,082 |
| Total Liabilities And Equity | $16,900 | $18,577 | $20,335 | $22,082 | $23,495 |